1403/02/08
فاطمه رودباری

فاطمه رودباری

مرتبه علمی: استادیار
ارکید:
تحصیلات: دکترای تخصصی
اسکاپوس:
دانشکده: دانشکده علوم پایه
نشانی: بابلسر. پردیس .دانشگاه مازندران.دانشکده علوم پایه.پروه میکروبیولوژی
تلفن: 01135302424

مشخصات پژوهش

عنوان
Prevalence and genetic diversity of norovirus genogroup II in children less than 5 years of age with acute gastroenteritis in Tehran, Iran
نوع پژوهش
JournalPaper
کلیدواژه‌ها
Norovirus Gastroenteritis Genotyping RdRp Capsid
سال
2018
مجله MEDICAL MICROBIOLOGY AND IMMUNOLOGY
شناسه DOI
پژوهشگران Fatemeh Roodbari ، Mahsa Farsi ، Zabihollah Shoja ، Arash Arashkia ، Behrooz Nejati ، Somayeh Jalilvand ، Alireza Nateghian ، Aliakbar Rahbarimanesh

چکیده

Viral gastroenteritis is a major public health problem worldwide. In Iran, very limited studies have been performed with regard to the epidemiology of noroviruses. This study aimed to evaluate the prevalence and molecular epidemiology of GII noroviruses in hospitalized children less than 5 years of age with acute gastroenteritis (AGE). A total of 210 stool specimens were collected from Ali Asghar Children’s Hospital and Bahrami Children’s Hospital in Tehran, from June 2015 to June 2016. The samples were screened by real-time RT-PCR for genogroup II (GII). Positive samples were genotyped by semi-nested PCR followed by Sanger sequencing and phylogenetic analysis. Norovirus was identified in 36 (17.1%) of 210 specimens. Based on genetic analysis of RdRp and capsid sequences, the strains were clustered into eight RdRp–capsid genotypes: GII.P4–GII.4 Sydney_2012 (41.7%), GII.Pe–GII.4 Sydney_2012 (30.6%), GII.P21–GII.3 (13.9%), GII.P16–GII.4 Sydney_2012 (2.8%), GII.P16–GII.12 (2.8%), GII.P2–GII.4 Sydney_2012 (2.8%), GII.P7–GII.7 (2.8%) and GII.P2–GII.2 (2.8%). We determined several different co-circulating norovirus genotypes in children < 5 years of age with AGE in our hospital in Tehran, Iran. Continued molecular surveillance of noroviruses, including typing of both RdRp and capsid genes, is important for monitoring emerging strains in our continued efforts to reduce the overall burden of norovirus disease.